Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(2):101-103; doi:10.1093/jnci/djk026
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Taylor, P. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Taylor, P. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

EDITORIAL

Prevention of Gastric Cancer: A Miss

Philip R. Taylor

Correspondence to: Philip R. Taylor, MD, ScD, Division of Cancer Epidemiology and Genetics, Genetic Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd., Rm. 7006, Bethesda, MD 20892-7236 (e-mail: ptaylor@mail.nih.gov).

The first 150 words of the full text of this article appear below.

Despite its declining global incidence and mortality, gastric cancer remains one of the most common cancers in the world, with nearly one million new patients expected to be afflicted with the disease this year. Given the 5-year relative survival rate among gastric cancer patients of only 23% (1), prevention is clearly the preferred strategy to reduce morbidity and mortality from this disease. In addition to secondary prevention approaches, which rely on screening for early detection, primary prevention efforts have focused on chemoprevention, using either nutritional interventions or anti–Helicobacter pylori therapies.

In this issue, Plummer et al. (2) report results of a nutritional intervention for the chemoprevention of gastric premalignancy. This randomized, double-blind, placebo-controlled trial tested the efficacy of daily supplementation for 3 years with a combination of three different nutrients—vitamin C (750 mg/day), vitamin E (600 mg/day), and beta-carotene (18 mg/day)—versus placebo on the regression . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?